Coronavirus Update: Another Post-Moderna Vaccine Death Reported In Japan
Not Seen As Product-Related
A third death has been reported in Japan following dosing with Moderna's mRNA vaccine and while an investigation is underway, it is not seen as product-related. Takeda has also signed a production and supply deal with Japan's government for Novavax's nanoparticle vaccine.
You may also be interested in...
Takeda and Moderna have identified the source of metallic particles in some lots of mRNA-1273 in Japan, but believe the two deaths identified to be coincidental. Pfizer starts protease inhibitor trial, and Rigel reports fostamatinib data.
Government and companies conducting urgent investigation into two deaths in recipients of Moderna vaccine, the causes of which remain unclear at this stage.
While delays to manufacturing have frustrated the vaccine’s submission, Novavax is still confident its nanoparticle-based jab will play a significant role in COVID-19.